Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000299868 | SCV000334835 | pathogenic | not provided | 2015-09-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001855114 | SCV002227761 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2C | 2021-03-25 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals with SGCG-related conditions. ClinVar contains an entry for this variant (Variation ID: 283032). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Phe151*) in the SGCG gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SGCG are known to be pathogenic (PMID: 18285821). |
Baylor Genetics | RCV001855114 | SCV004201054 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2C | 2023-03-15 | criteria provided, single submitter | clinical testing |